Bioera S.p.A.

BIE

IT0005516130

Food Processing

Market Closed - Borsa Italiana Other stock markets 16:44:59 21/06/2024 BST			5-day change	1st Jan Change
0.0668 ^EUR	-0.60%		0.00%	+24.86%

2023	Bioera S.p.A. Reports Earnings Results for the Half Year Ended June 30, 2023	CI
2023	Bioera S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2022	CI

Bioera S.p.A. Reports Earnings Results for the Half Year Ended June 30, 2023

December 18, 2023

Bioera S.p.A. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported revenue was EUR 0.014 million compared to EUR 0.418 million a year ago. Net loss was EUR 1.64 million compared to EUR 0.754 million a year ago.

Latest news about Bioera S.p.A.

Bioera S.p.A. Reports Earnings Results for the Half Year Ended June 30, 2023	12-18	CI
Bioera S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2022	20/04/23	CI
Bioera S.p.A. Reports Earnings Results for the Half Year Ended June 30, 2022	05/09/22	CI
Bioera S.p.A. announced that it expects to receive €15 million in funding	20/04/22	CI
Bioera S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2021	14/04/22	CI
Bioera Cancels Helon Merger On Valuation Issues	27/12/21	MT
Bioera S.P.A. Reports Earnings Results for the Half Year Ended June 30, 2021	29/09/21	CI
Helon srl agreed to acquire an unknown majority stake in Bioera S.p.A..	08/08/21	CI
Bioera S.P.A. Reports Earnings Results for the Full Year Ended December 31, 2020	14/04/21	CI
Sergio Paolino acquired 89.9% stake in Bioera Re Srl from Bioera S.p.A. for €0.55 million.	27/10/19	CI
Idea Team Srl cancelled the acquisition of 24% stake in Ki Group S.p.A. (BIT:KI) from Bioera S.p.a.	04/07/17	CI
Meditalia Srl announced that it expects to receive €0.55 million in funding from Bioera S.p.a	19/01/17	CI
Idea Team Srl signed an agreement to acquire 24.6% stake in Ki Group S.p.A. (BIT:KI) from Bioera S.p.a for €6.9 million.	04/07/16	CI
Splendor Investment Holdings Ltd cancelled the acquisition of Unopiù S.p.A. from Bioera S.p.a.	24/04/16	CI
Splendor Investment Holdings Ltd agreed to acquire Unopiù S.p.A. from Bioera S.p.a.	24/04/15	CI
Unopiù S.p.A. announced that it expects to receive €4 million in Bioera S.p.A.	23/06/14	CI
Bioera Announces Consolidated Earnings Results for the Year 2013	02/05/14	CI
Bioera Proposes Dividend for 2013	02/05/14	CI
Daniela Santanche, President of Bioera S.p.a, sold 5.55% stake in Bioera S.p.a (BIT: BIE) for €0.74 million.	23/10/13	CI
Visibilia Srl announced that it has received €0.90 million in funding from Bioera S.p.a.	30/07/13	CI
D1 Partecipazioni Srl acquired 14.91% stake in Bioera S.p.a from First Capital Spa for €2.4 million.	24/05/13	CI

Chart Bioera S.p.A.

Duration

Period

More charts

Company Profile

Bioera SpA is an Italy-based company engaged in the production and distribution of organic products, natural cosmetics and traditional food products. The companyâs activities are divided into two sectors. The Biological and Natural products sector, through its subsidiaries and affiliated entities, is active in the distribution of natural and organic products; production of organic food from vegetables; manufacture of oil from organic agriculture, and distribution of traditional food products, as well as in the sector of natural origin cosmetics. The Holding sector provides activities of the Company as a parent of the group. The Company controls entities, such as Organic Oils Italia Srl, La Fonte della Vita Srl, KI Group SpA and Organic Food Retail Srl.

Sector

Food Processing

Calendar

24/09/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
BIOERA S.P.A.	+24.86%	1.47M
ZHEJIANG NHU COMPANY LTD.	+13.80%	8.17B
BELLRING BRANDS, INC.	+0.47%	7.31B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	-8.08%	5.43B
THE SIMPLY GOOD FOODS COMPANY	-6.72%	3.69B
BYHEALTH CO., LTD	-19.73%	3.2B
XIAMEN KINGDOMWAY GROUP COMPANY	-12.00%	1.21B
HERBALIFE LTD.	-26.74%	1.12B
SIRIO PHARMA CO., LTD.	+0.89%	868M
USANA HEALTH SCIENCES, INC.	-14.98%	868M